About Us

        Zhejiang AngLiKang Pharmaceutical Co., Ltd. was founded in 2001 based on original AngliKang Pharmaceutical Plant founded in 1994. In December, 2014, it was reformed to present incorporated company. Currently it has become a modern pharmaceutical enterprise integrated of bulk pharmaceutical materials, pharmaceutic preparation and medical empty capsule. Main products are cephalosporins antibacterial, angiocarpy drugs and gastrointestinal tract drugs. Our company covers an area of 500mu and a construction area of over 120,000 square meters. Nowadays there are more than 1000 employees, including, 245 with college degree or above. Under Zhejiang AngLiKang Pharmaceutical Co., Ltd., there are Zhejiang AngLiTai Pharmaceutical Co., Ltd., Zhejiang AngliKang Capsule Co., Ltd., Zhejiang Guangkang Pharmaceutical Co., Ltd. and Jiangsu Yuexin Pharmaceutical Co., Ltd. In 2015, we realized sales revenue of RMB 860 million Yuan, profit and tax of RMB 130 million Yuan.  It is first company of “Shengzhou Top 30 Industrial Enterprise” and “Shaoxing Top 20 Industrial Enterprise”. Our credit rating is AAA level.

        In addition, our company is state high-tech enterprise. There is provincial enterprise technology center, provincial enterprise research institute and “expert academician work station”. Relying on all platforms and rich resources, our company positively develops new products and improves traditional technique in order to to promote our comprehensive competitive power. Our company has 15 authorized patents for invention and 52 official documents of pharmaceutical production.

        Major projects: technology improvement of cephalosporin; extension of industrial chain of cephalosporin; comprehensive preparation project.

        Relying on long-term technical innovation and product research, our company will have a brilliant future. In 2015, our sales revenue will exceed RMB 1 billion Yuan. We will make efforts to develop our company to be an innovation-type international enterprise with powerful comprehensive competitiveness.